COVID-19: Global Agencies Step Up Focus On Real-World Data
International Clinical Cohorts Proposed To Share Expertise
Executive Summary
There is much talk around the importance of clinical trials in finding new treatments and vaccines for COVID-19 patients, but observational studies in clinical practice also have a vital role to play, including the impact on pregnant women.
You may also be interested in...
Coronavirus Update: Setback With Hydroxychloroquine, Slowdown In UK ADR Reports, But Novel Drugs Begin Trials
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national, European and global level.
Coronavirus Update: Big Trials, New Vaccine Platforms, And Fake Chloroquine In Africa
In addition to our daily in-depth coverage of key events relating to the coronavirus, we’re bringing you a periodic round-up of other pandemic developments. This edition covers events at the national and EU level.
New EMA System By Year End To Monitor COVID-19 Vaccine Safety
During a virtual workshop with global drug regulators, the European Medicines Agency discussed its plans to build a new EU system to track the safety of COVID-19 vaccines. Also, regulators agreed on exchanging information on observational studies and real-world data relating to the coronavirus pandemic.